No one wants to catch the flu, and the best line of defense is the seasonal influenza vaccine. But producing an effective annual flu shot relies on accurately predicting which flu strains are most likely to infect the population in any given season. It requires the coordination of multiple health centers around the globe as the virus travels from region to region. Once epidemiologists settle on target flu strains, vaccine production shifts into high gear; it takes approximately six months to generate the more than 150 million injectible doses necessary for the American population.
More at the source: Influenza: The search for a universal vaccine
Amyn is currently getting his PhD as an experimental immunologist in the department of Microbiology and Immunology at Vanderbilt University through the Vanderbilt Vaccine Center.
One aspect of Amyn’s work relates to the application of chemical biology and structural bioinformatics principles to the design of immunogens capable of eliciting protective antibody responses against target antigens. In addition, Amyn also intends to work on engineering antibodies with improved antigen affinity and neutralization potency. He hopes his efforts will culminate in the development of a clinical product candidate that will contribute to the improvement of human health.
Amyn’s involvement as a member of the Chemical Biology of Infectious Diseases Training Program funded by the National Institutes of Health has allowed him to explore additional interests that tap into other areas related to his work. As a result, he has an appreciation for functional genomics and computational biology.
Previously on Ismailimail…